Skip to Content

472 (Imatinib Mesylate 100 mg)

Pill with imprint 472 is Yellow, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Sun Pharma Global FZE.

Imatinib is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; chronic eosinophilic leukemia; myeloproliferative disorders; dermatofibrosarcoma protuberans (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 472

Imatinib Mesylate

Imprint:
472
Strength:
100 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sun Pharma Global FZE
National Drug Code (NDC):
47335-0472

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide